Statement Of Cash Flows [Abstract]

Redcare Pharmacy N.V. - Filing #5831390

Concept 2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
As at
2024-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
As at
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
46,356,000 EUR
0 EUR
45,464,000 EUR
0 EUR
45,464,000 EUR
892,000 EUR
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
11,606,000 EUR
12,041,000 EUR
12,041,000 EUR
435,000 EUR
0 EUR
0 EUR
0 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
17,392,000 EUR
16,597,000 EUR
Adjustments for depreciation and amortisation expense
68,217,000 EUR
57,288,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
519,000 EUR
277,000 EUR
Adjustments for share-based payments
3,182,000 EUR
8,997,000 EUR
Adjustments for losses (gains) on disposal of non-current assets
0 EUR
140,000 EUR
Income taxes paid (refund), classified as operating activities
614,000 EUR
1,444,000 EUR
Cash flows from (used in) operating activities
22,126,000 EUR
61,456,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
256,000 EUR
23,441,000 EUR
Purchase of property, plant and equipment, classified as investing activities
8,744,000 EUR
6,437,000 EUR
Purchase of intangible assets, classified as investing activities
33,407,000 EUR
31,784,000 EUR
Interest received, classified as investing activities
6,827,000 EUR
4,639,000 EUR
Cash flows from (used in) investing activities
8,381,000 EUR
59,963,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
0 EUR
29,391,000 EUR
Payments of lease liabilities, classified as financing activities
8,250,000 EUR
7,303,000 EUR
Interest paid, classified as financing activities
8,969,000 EUR
8,022,000 EUR
Cash flows from (used in) financing activities
17,936,000 EUR
15,046,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
12,571,000 EUR
16,539,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
161,000 EUR
844,000 EUR
Cash and cash equivalents
96,892,000 EUR
84,160,000 EUR
66,777,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.